drugset / Trial / NCT00268645
Insulin Glargine in Type 2 Diabetes
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this project is to confirm the efficacy and safety profile of Insulin glargine in daily practice and to improve the physicians' knowledge and experience concerning Insulin glargine
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | — |